drugset / Trial / NCT07433569
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the pharmacokinetics (PK) and safety of symbicort aerosphere and symbicort pressurized metered dose inhaler (pMDI) in participants with asthma aged 4 to less than 12 years.
Timeline
- Start
- 2026-03-05
- Primary completion
- 2026-06-26
- Completion
- 2026-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | — | Inhaled |
| Subject | Formoterol | Other / unclassified | — | Inhaled |